Behavioral Health
Sexual assault: acute care and forensic considerations
— ~1 in 5 women and ~1 in 38 men report lifetime contact sexual violence (CDC NISVS)
— >50% of assaults involve a known perpetrator (partner, acquaintance, family member)
— Peak incidence ages 12–34; LGBTQ+, disabled, incarcerated, and unhoused populations at markedly elevated risk
— Drug-facilitated sexual assault (DFSA) increasingly common — ethanol is the most common agent, followed by benzodiazepines, GHB, ketamine
— Vague pelvic, genital, or anorectal pain without clear etiology
— New STI, unintended pregnancy, or request for emergency contraception in a hesitant patient
— Acute PTSD-like presentation, dissociation, self-harm, or substance overdose
— Unexplained injuries (bruising in clothing-covered areas, ligature marks, oral trauma)
— Pediatric/adolescent recurrent UTIs, anogenital complaints, sudden behavior change
— Adult with cognitive impairment and unexplained genital injury (consider elder/vulnerable adult abuse)
— Patient-led pace, explicit consent for each step, minimize retelling
— Offer same-gender provider when possible; allow support person except during forensic interview
— Use neutral, non-judgmental language; avoid "alleged" framing in clinical notes

— Triage to private, quiet space; one provider as primary point of contact
— Confirm patient is safe from perpetrator before extensive history
— Document patient's own words in quotes when possible; avoid leading questions
— Use ED template or SANE-driven interview to avoid repeated retelling (re-traumatization)
— Who: Known vs. stranger, number of assailants, ongoing threat
— What: Specific acts (oral, vaginal, anal penetration; digit/object/penis; ejaculation; condom use; biting; strangulation)
— When: Date/time of assault — drives prophylaxis windows and evidence yield
— Where: Location, surfaces (for trace evidence), restraints
— Weapons/force: Threats, weapons, physical violence, strangulation (red flag for lethality)
— Bathing, douching, urinating, defecating, brushing teeth, eating/drinking, changing clothes
— These reduce but do not eliminate evidence yield
— LMP, contraception, possibility of pre-existing pregnancy
— HIV status, prior STIs, immunization status (hepatitis B, HPV, tetanus)
— Allergies (esp. to prophylaxis drugs: doxycycline, ceftriaxone, antiretrovirals)
— Mental health history, prior trauma, current substance use, suicidality
— Ask specifically: "Did anyone put hands, an arm, or anything around your neck?"
— Symptoms: voice change, dysphagia, neck pain, petechiae, LOC, incontinence
— Even minimal external findings can mask carotid dissection or laryngeal injury

— Strangulation → airway edema, carotid injury, anoxic brain injury
— Penetrating/blunt trauma → hemorrhage, intracranial injury
— Drug-facilitated assault → altered mental status, respiratory depression, hypothermia
— Trauma vitals (HR, BP, GCS, SpO₂) before forensic exam; hemodynamic instability mandates trauma workup first
— Head/face: Periorbital bruising, lip/oral lacerations, frenulum tears, tooth fractures
— Neck: Petechiae (eyelids, conjunctiva, scalp), linear marks, hand-pattern bruising, subconjunctival hemorrhage, hoarseness, stridor
— Trunk/extremities: Bite marks (swab for DNA before cleaning), patterned bruises, defensive wounds on forearms/hands, ligature marks at wrists/ankles
— Anogenital exam: Often normal even after penetrative assault — absence of injury does NOT exclude assault
— Posterior fourchette tears, fossa navicularis abrasions, hymenal transections (acute)
— Perianal fissures, rectal tears
— Toluidine blue dye or colposcopy enhances detection of microtears
— Document using clock-face orientation (patient in lithotomy: 12 o'clock = anterior)

— Pregnancy test (urine or serum β-hCG) — mandatory in all patients with childbearing capacity before emergency contraception
— HIV antigen/antibody (4th-gen) — baseline negative supports later seroconversion claim
— Hepatitis B surface antigen, anti-HBs, anti-HBc — guides vaccination/HBIG decision
— Hepatitis C antibody — baseline
— Syphilis (RPR or treponemal screen)
— NAAT for gonorrhea and chlamydia — site-specific (vaginal/cervical, rectal, pharyngeal based on exposure)
— Wet mount / Trichomonas NAAT if vaginal exposure
— CBC, CMP, coagulation if significant trauma or PEP planned (baseline renal/hepatic function)
— Urine drug screen + expanded panel (GHB, ketamine, benzodiazepines beyond standard immunoassay)
— Serum ethanol level
— Collect ASAP — GHB clears urine within ~12 hours, many benzodiazepines within 72 hours
— Forensic toxicology samples are collected separately by SANE with chain of custody
— CT head for LOC, severe headache, neuro deficit, strangulation with neuro symptoms
— CTA neck for strangulation with neuro symptoms, voice change, or significant external findings — rule out carotid/vertebral artery dissection
— Soft tissue neck CT for suspected laryngeal/tracheal injury
— CT abdomen/pelvis for blunt abdominal trauma, peritoneal signs
— Plain films for suspected fractures

— Standard window ≤120 hours (5 days) post-assault in most US jurisdictions; some extend to 7 days
— Yield highest within first 24 hours but never refuse a kit based on time alone — defer to local protocol
— Conducted by SANE/SAFE-trained clinician when available; chain of custody documented at every transfer
— Oral, vaginal, cervical, anal, and penile swabs (per exposure history)
— External genital swabs and combings (pubic hair)
— Fingernail scrapings/clippings (defensive evidence)
— Bite mark swabs (saline-moistened, before any cleansing)
— Clothing worn during or immediately after assault (paper bags, not plastic — prevents mold)
— Reference samples: buccal swab or blood for patient DNA
— Known/foreign hair samples, debris
— Hair sample at ~4–5 weeks post-event can confirm single-dose drug exposure
— Blood + urine collected with chain of custody for GC-MS confirmation
— CTA neck for vessel injury
— MRI brain if persistent neuro symptoms with negative CT
— Flexible laryngoscopy for voice change, dysphagia, hemoptysis
— Repeat β-hCG; transvaginal ultrasound if positive

— (1) Medical stabilization — treat trauma, strangulation injury, intoxication
— (2) Forensic evidence collection — within window, with consent
— (3) Prophylaxis + psychosocial support + safety
— Pregnancy risk? → Emergency contraception (EC) regardless of cycle day if reproductive capacity
— STI exposure? → Empiric prophylaxis for gonorrhea, chlamydia, trichomonas; consider syphilis
— HIV exposure risk? → Assess source factors + exposure type → offer HIV PEP within 72 hours
— Hepatitis B susceptible? → Vaccinate ± HBIG
— Tetanus status? → Update if wound and last dose >5 years
— Mental health acuity? → Suicidality, intoxication, dissociation
— Safety at discharge? → Return to perpetrator? Housing? Intimate partner violence overlap?
— Highest risk: Receptive anal exposure, known HIV+ source, mucosal trauma, multiple assailants, ejaculation
— Moderate: Receptive vaginal, oral with ejaculation/trauma
— Lower: Oral without ejaculation, condom use without breakage
— Decision: Offer PEP for any meaningful mucosal exposure if presenting within 72 hours; engage in shared decision-making for borderline cases
— Any LOC, incontinence, persistent neuro symptoms, voice change → admit or extended observation + imaging
— Mild symptoms with normal exam → discharge with strict return precautions, strangulation follow-up clinic

— Levonorgestrel 1.5 mg PO ×1 — OTC, most effective within 72h, declines after; less effective with BMI >30
— Ulipristal acetate 30 mg PO ×1 — prescription; effective up to 120 hours; preferred for BMI 26–35 and for presentations 72–120h
— Copper IUD — most effective (>99%); can be placed up to 120h; provides ongoing contraception
— Levonorgestrel 52 mg IUD — newer evidence supports as EC up to 120h
— Antiemetic (ondansetron) recommended with oral EC
— Ceftriaxone 500 mg IM ×1 (1 g if ≥150 kg) — gonorrhea
— Doxycycline 100 mg PO BID ×7 days — chlamydia (azithromycin 1 g if pregnant or adherence concerns)
— Metronidazole 500 mg PO BID ×7 days — trichomonas/BV
— Preferred: Tenofovir disoproxil fumarate (TDF) 300 mg + emtricitabine (FTC) 200 mg PO daily + dolutegravir 50 mg PO daily (or raltegravir 400 mg BID)
— Alternatives: TAF/FTC + DTG; bictegravir-based regimens increasingly used
— Baseline HIV test, renal function, hepatitis serologies before starting
— Counsel on side effects (GI, headache), adherence, follow-up at 4–6 weeks and 3 months
— Unvaccinated/unknown → HBV vaccine series + HBIG (if source HBsAg+ or high risk)
— Vaccinated with documented response → no action

— Wound care: Irrigate and close lacerations per standard ED practice; document size, depth, location with photos before repair
— Pelvic exam with speculum — only as needed for evidence collection and injury assessment; smallest comfortable speculum, generous lubrication (water-based; avoid silicone if DNA collection)
— Anoscopy if rectal bleeding, severe pain, or suspected internal injury
— Foley catheter only if urinary retention, severe perineal trauma, or surgical need — avoid routine placement (re-traumatizing)
— Most effective EC method
— Requires trained provider; can be placed in ED or rapid referral
— Contraindications: active PID, pregnancy, uterine anomaly, copper allergy, Wilson disease
— Counsel that ongoing contraception is provided for 10–12 years
— Airway assessment paramount — low threshold for early intubation if expanding hematoma, stridor, or progressive edema
— CTA neck findings of dissection → vascular surgery consult, antiplatelet or anticoagulation per protocol
— Laryngeal fracture → ENT consult, possible surgical repair
— GHB intoxication → supportive (airway, monitoring); resolves within hours; flumazenil not indicated
— Benzodiazepine intoxication → supportive; avoid flumazenil (seizure risk in chronic users)
— Doxycycline + antacids/iron/calcium → separate by 2 hours
— Dolutegravir + polyvalent cations → space dosing; also caution in early pregnancy (small NTD signal — discuss alternatives if pregnancy planned)
— Ulipristal delays ovulation; do not co-administer with hormonal contraception within 5 days (mutual interference) — restart hormonal contraception 5 days after ulipristal

— Estimated <5% of cases reported; perpetrators often caregivers or institutional staff
— Presentations: unexplained genital injury/bleeding, new STI, recurrent UTI, sudden behavior change, fear of specific caregiver, poor hygiene
— Cognitive impairment complicates consent assessment — lack of capacity to consent = assault even without overt force
— Mandatory reporting to Adult Protective Services (APS) in all 50 states for vulnerable adults
— Document patient's ability to understand sexual activity, voluntariness, and consequences
— Dementia, delirium, severe intellectual disability typically preclude consent
— Capacity is decision-specific and may fluctuate
— Atrophic vaginal/vulvar tissue more prone to laceration — injuries may be more visible but also confused with age-related changes
— Skin fragility → bruising patterns harder to date; obtain photodocumentation
— Pre-existing incontinence, prolapse may obscure findings
— HIV PEP renal dosing: TDF requires CrCl ≥60; for CrCl 30–59, dose-adjust TDF or switch to TAF/FTC (preferred in CKD); avoid TDF if CrCl <30
— Doxycycline — no renal/hepatic adjustment needed (good choice in CKD)
— Ceftriaxone — no dose adjustment for renal impairment
— Metronidazole — reduce dose in severe hepatic impairment
— Levonorgestrel/ulipristal — caution in severe hepatic impairment; ulipristal not studied
— Dolutegravir + metformin → increases metformin levels (monitor)
— Doxycycline + warfarin → potentiates INR (monitor closely)
— Ondansetron + QT-prolonging meds → ECG before dosing

— Sexual assault during pregnancy strongly associated with intimate partner violence; screen for IPV
— EC not applicable if already pregnant; confirm with β-hCG
— Fetal monitoring if ≥20 weeks gestation and any abdominal trauma; consider Kleihauer-Betke if Rh-negative
— Anti-D immunoglobulin for Rh-negative patients with abdominal trauma
— STI prophylaxis: azithromycin 1 g (instead of doxycycline) for chlamydia; ceftriaxone and metronidazole safe
— HIV PEP: continue standard regimen; dolutegravir now considered safe throughout pregnancy (NTD signal not confirmed in later data)
— OB consult; placental abruption risk if blunt trauma
— Mandatory reporting to CPS in all 50 states for any suspected child sexual abuse — clinical suspicion alone triggers report, not proof
— Refer to child abuse pediatrician / Child Advocacy Center when available — minimizes repeat interviews, expert forensic exam
— Acute (<72–120h) → forensic kit + prophylaxis; non-acute → focus on medical, psychological, safety
— Anogenital exam typically normal even with confirmed abuse — never use normal exam to refute history
— Adolescents: most jurisdictions allow minors to consent to STI testing, EC, and confidential care without parental consent — know state laws
— STI prophylaxis dosing pediatric: ceftriaxone 500 mg IM if ≥45 kg; weight-based if smaller; doxycycline only if ≥8 years and ≥45 kg (otherwise azithromycin)
— Substantially underreported; often delayed presentation
— Anal/oral exposure most common; assess for rectal trauma
— Same prophylaxis principles (no EC needed)
— Address shame, stigma, sexuality concerns explicitly
— Use chosen name/pronouns; do not assume anatomy or partners
— Increased baseline rates of sexual violence, especially trans women
— Higher victimization rates; perpetrators often caregivers
— Communication accommodations (interpreter, AAC device); never use family as interpreter for assault disclosure

— Genital/anorectal injury with hemorrhage, infection, rectovaginal fistula (rare)
— Strangulation sequelae: carotid/vertebral dissection, stroke (may be delayed days–weeks), anoxic brain injury, laryngeal fracture, miscarriage
— Pregnancy from assault — ~5% of reproductive-age assaults
— STI acquisition: gonorrhea, chlamydia, trichomonas, syphilis, HIV, HBV, HCV, HPV, HSV
— HIV seroconversion: ~0.1–3% per exposure depending on type; markedly reduced by PEP
— Chronic pelvic pain, dyspareunia, vulvodynia
— Recurrent UTI, irritable bowel syndrome, fibromyalgia (functional somatic overlap)
— HPV → cervical/anal dysplasia; long-term cancer screening implications
— Chronic hepatitis B or C if not prevented
— Acute stress disorder (≤1 month) → PTSD (>1 month) develops in 30–50% of survivors
— Major depression, suicidality, panic disorder, substance use disorder
— Self-harm; suicide attempts elevated 4–10× baseline
— Dissociative symptoms, sleep disturbance, nightmares, flashbacks
— Sexual dysfunction, fear of intimacy
— Job loss, housing instability, relationship dissolution
— Re-traumatization through legal proceedings
— Stigma, victim-blaming, particularly in close-knit communities
— Re-traumatization from repeated histories, invasive exams without consent, dismissive providers
— Missed strangulation injuries → delayed stroke
— Inadequate PEP counseling → poor adherence → seroconversion
— Loss of evidence due to improper collection/storage
— Premature disposition to unsafe environment

— Strangulation with LOC, persistent neuro symptoms, or imaging-confirmed vascular injury → step-down/ICU for monitoring + anticoagulation
— Hemodynamic instability from trauma or hemorrhage
— Severe overdose/intoxication requiring airway support
— Major surgical injury (laparotomy, complex repair)
— Severe DFSA with prolonged altered mental status
— Active suicidal ideation with plan/intent
— Inability to maintain safety (intoxication, severe dissociation, psychosis)
— No safe disposition
— Voluntary admission preferred; involuntary hold per state criteria if imminent danger
— SANE/SAFE nurse — forensic exam (first call when available)
— OB/GYN — pregnancy complications, IUD placement, complex genital injury
— Trauma surgery — significant blunt/penetrating trauma
— ENT — laryngeal injury, strangulation with airway concern
— Vascular surgery/neurology — carotid/vertebral dissection
— Infectious disease — complex PEP decisions, immunocompromised host
— Pediatrics / child abuse pediatrician — minors
— Psychiatry — suicidality, acute psychosis
— Social work / victim advocate — safety planning, resources, hotline (RAINN 1-800-656-HOPE)
— Law enforcement — only with patient consent (adult, capable); mandatory for minors and vulnerable adults

— Most common type of sexual assault; perpetrator is current/former partner
— Frequently coexists with physical IPV, financial abuse, coercive control
— Patients less likely to identify as "assault" — use specific behavioral questions
— Mandates IPV-specific safety planning, lethality assessment (HARK, Danger Assessment)
— Strangulation history is a major lethality predictor (8× increased risk of homicide)
— Voluntary or involuntary intoxication
— Patient may have fragmented or absent memory
— Toxicology windows short — collect early
— Belief of patient should not be diminished by intoxication
— Distinct legal definitions; mandatory CPS reporting
— Often chronic, involves grooming, not single event
— Refer to Child Advocacy Center
— Capacity-based determination
— Mandatory APS reporting
— Red flags: scripted history, accompanied by controlling individual, tattoos/branding, no ID, multiple ED visits, STI/pregnancy in young patient
— National Human Trafficking Hotline: 1-888-373-7888
— Engage trafficking-specific resources; offer private interview away from accompanying person
— Below age of consent (varies by state, typically 16–18)
— Mandatory report regardless of "consent"
— Romeo-and-Juliet exceptions in some states
— Inmates, patients in psychiatric facilities, military
— PREA (Prison Rape Elimination Act) protocols; military SAFE protocols (Restricted vs Unrestricted reporting)

— Posterior fourchette tears, friction abrasions can occur with consensual intercourse
— Injury alone does not establish non-consent; history is paramount
— Document objectively; do not editorialize
— Straddle injury (especially pediatric — bicycle, playground)
— Obstetric trauma
— Foreign body insertion (psychiatric, accidental)
— Sexual practices involving objects/BDSM (consensual)
— Vulvovaginitis, lichen sclerosus, atrophic vaginitis
— Postcoital bleeding from cervical polyp/cancer
— Hemorrhoids, anal fissure from constipation
— Urethral prolapse (pediatric, postmenopausal)
— Mongolian spots (pediatric)
— Coining/cupping (cultural healing practices) — document without prejudice
— Coagulopathies (ITP, hemophilia, anticoagulant use)
— Henoch-Schönlein purpura, leukemia
— Conversion disorder with pseudoseizures or memory gaps
— False memory in dissociative states
— Acute psychosis with sexual delusions
— These rarely fully account for a complete clinical picture — err on the side of believing and providing care
— Voluntary intoxication with amnesia from alcohol or polysubstance
— Patient genuinely may not know — still warrants evaluation for assault given vulnerability during blackout
— Extremely rare; never the initial assumption
— Beware diagnostic anchoring; never refuse care based on suspicion of fabrication

— EC (levonorgestrel or ulipristal) — given in ED, single dose
— STI prophylaxis: Doxycycline 100 mg BID ×7 days (or azithromycin 1 g ×1 if pregnancy/adherence); ceftriaxone already given IM; metronidazole 500 mg BID ×7 days
— HIV PEP starter pack (3–28 days depending on local supply) — TDF/FTC + dolutegravir; arrange ID follow-up within 1 week
— HBV vaccine — series initiation; second dose at 1 month, third at 6 months
— HPV vaccine initiation if eligible
— Tdap if indicated
— Antiemetic for PEP nausea (ondansetron PRN)
— Sleep: Trazodone or hydroxyzine preferred over benzodiazepines
— Medication purposes, schedules, side effects
— Symptoms requiring return: worsening pain, fever, vaginal/rectal bleeding, suicidal thoughts, PEP side effects (rash, jaundice, severe GI)
— Follow-up appointments scheduled before discharge when possible
— Crisis line: RAINN 1-800-656-HOPE, local rape crisis center
— 1–2 weeks: Mental health check-in, PEP tolerability, wound recheck
— 4–6 weeks: Repeat STI testing (NAAT GC/CT), pregnancy test, repeat HIV (4th-gen), syphilis RPR
— 3 months: Repeat HIV, HCV
— 6 months: Final HIV, HCV, HBV testing
— Annual: Cervical cancer screening per USPSTF; HPV-related surveillance
— Establish primary care relationship; trauma-informed provider
— Mental health: trauma-focused CBT, EMDR, prolonged exposure therapy
— SSRIs (sertraline, paroxetine) FDA-approved for PTSD; first-line pharmacotherapy
— Substance use disorder screening and treatment
— Reproductive health: ongoing contraception planning, PrEP consideration if ongoing risk

— 48–72 hours: Phone or in-person check by victim advocate or SANE follow-up program
— 1 week: PEP tolerance, lab review (baseline HIV/HBV/HCV/syphilis), mental health screen (PHQ-9, PCL-5)
— 2 weeks: Repeat mental health screen — suicide risk peak window
— 4–6 weeks: Repeat STI NAAT (gonorrhea, chlamydia, trichomonas), β-hCG, HIV Ag/Ab, RPR
— 3 months: HIV, HCV, RPR
— 6 months: HIV (if HCV+ or high-risk source), HCV RNA, HBV serologies
— 12 months: HPV-related screening as appropriate
— Baseline + 2-week + 4-week: CBC, BMP (renal function), LFTs
— Adherence counseling at each visit — completion rates only ~40% without support
— Side effect management: nausea (ondansetron), fatigue, headache, insomnia
— Trauma-focused CBT is first-line psychotherapy (highest evidence for PTSD)
— Other evidence-based: prolonged exposure (PE), cognitive processing therapy (CPT), EMDR
— Pharmacotherapy: SSRIs (sertraline, paroxetine FDA-approved), SNRIs (venlafaxine) — start low, titrate; avoid benzodiazepines for PTSD (worsens long-term outcomes)
— Prazosin for trauma-related nightmares
— Avoid debriefing (single-session critical incident debriefing) — may worsen outcomes
— Pregnancy test at 4–6 weeks even with EC use (EC failure rate 1–3%)
— Discuss ongoing contraception, reproductive plans
— Discuss options if pregnancy results from assault — neutral, comprehensive counseling
— Clinical reassessment at 1 week and 1 month for delayed vascular/neurologic symptoms
— Repeat imaging only if symptoms develop
— Pelvic floor physical therapy for chronic pelvic pain/dyspareunia
— Sleep hygiene, exercise, nutrition counseling
— Peer support groups (RAINN, local rape crisis centers)

— Separate consent for (1) medical exam, (2) forensic evidence collection, (3) photography, (4) release of evidence to law enforcement, (5) prophylaxis medications
— Patient may consent to some and decline others
— May withdraw consent at any point; honor immediately
— Document consent process explicitly
— Adult competent survivors: In most US states, reporting to law enforcement is the patient's choice — clinician does NOT mandatorily report. Exceptions: some states require reporting of injuries from violent crime (gunshot, stab wounds); know your state.
— Minors: Mandatory CPS report for suspected child sexual abuse — clinical suspicion suffices; report before discharge
— Vulnerable adults (elderly, cognitively impaired, disabled): Mandatory APS report
— Active-duty military: Restricted vs Unrestricted reporting — Restricted preserves confidentiality while allowing care
— Human trafficking: Reporting varies by state and patient age
— Every transfer of evidence documented (who, when, where, signature)
— Break in chain of custody can render evidence inadmissible
— Store kit per institutional protocol; many states allow anonymous/"Jane Doe" kits stored without immediate law enforcement involvement, giving survivors time to decide
— Do NOT discuss case with family, partners, employers without patient consent
— Beware accompanying persons who may be perpetrators or controllers
— Interpreter services — never use family/companion
— Discharge to unsafe environment is a sentinel safety event. Coordinate with social work, DV shelters, hotel vouchers, family/friends before discharge.
— Communication to outpatient provider — share only what patient consents to share; some EMRs flag sensitive visits
— Prescribe enough PEP and follow-up scheduled to prevent care gaps
— Vicarious trauma is real — peer support, debrief programs, EAP

— HIV PEP: ≤72 hours (start ASAP)
— Emergency contraception (levonorgestrel): ≤72h (declining efficacy)
— Ulipristal acetate: ≤120h
— Copper IUD: ≤120h (most effective EC)
— Forensic evidence kit: ≤120h (often, jurisdiction-dependent; up to 7 days in some)
— Hepatitis B PEP (HBIG): ≤7 days for sexual exposure
— Tetanus prophylaxis: ASAP if wound and last dose >5 years

→ Answer set: Ceftriaxone + doxycycline + metronidazole + EC (levonorgestrel or ulipristal) + HIV PEP (TDF/FTC + dolutegravir) + HBV vaccine + offer SANE exam + follow-up in 1 week. The wrong answer is "wait for STI results."
→ Best EC: Copper IUD (most effective, unaffected by BMI, within 120h window). Levonorgestrel less effective beyond 72h and with obesity. PEP not offered — outside 72h window. Still offer STI prophylaxis, HBV vaccine, forensic kit.
→ Next step: CTA of the neck. Admit for observation. The miss is discharging — delayed carotid dissection causes stroke days later.
→ First action: Mandatory report to CPS (before workup completion is fine — but the report must happen). Refer to Child Advocacy Center. Do NOT confront alleged perpetrator. Do NOT discharge to same household.
→ Mandatory APS report. Forensic exam with capacity documentation. Separate from suspected caregiver. Engage social work, ombudsman.
→ Provide full medical and forensic care anyway (anonymous kit option in many states). The patient's autonomy regarding law enforcement is preserved. Wrong answer: "refuse forensic exam unless reporting to police."
→ Continue PEP, add ondansetron, check renal function/CBC/LFTs, repeat HIV at 4–6 weeks. Do not stop PEP for nausea alone.
→ Psychiatric evaluation/admission, suicide risk assessment, start SSRI (sertraline), trauma-focused therapy referral. Do NOT prescribe benzodiazepines for PTSD.

Sexual assault care is a parallel-tracked ED encounter in which medical stabilization, time-sensitive prophylaxis, forensic evidence preservation, and trauma-informed psychosocial support must all happen together — never sequentially.
— Medical: Stabilize trauma, assess strangulation (CTA neck if any neuro symptoms), treat injuries
— Forensic: SANE-led kit within ~120 hours, chain of custody, patient consent at every step
— Prevention: EC (levonorgestrel/ulipristal/copper IUD per window + BMI), STI prophylaxis (ceftriaxone + doxycycline + metronidazole), HIV PEP ×28d if ≤72h (TDF/FTC + dolutegravir), HBV vaccine ± HBIG, HPV vaccine, Tdap

